Back to top

UCLA Testing Prostate Cancer Hormone Suppressor as COVID-19 Treatment for Men

Researchers at UCLA are conducting a trial at the Veterans Affairs (VA) Greater Los Angeles Healthcare System and at other VA sites across the country to study if temporarily suppressing male hormones reduces the severity of COVID-19 illness in men.

Men are more likely to get infected and die of COVID-19 when compared to women, and researchers believe that this information may be helpful for developing future therapeutic interventions. Specifically, scientists are studying a protein receptor called TMPRSS2. This protein is abnormal in half of prostate cancer patients and is the same receptor researchers believe the virus uses to enter and attack the lungs. When men take the medication degarelix, an FDA-approved hormone suppresser used for prostate cancer, the body temporarily shuts down the production of TMPRSS2, which may block the virus from entering lung tissue.

"It's kind of like a lock and key," said Matthew Rettig, MD, professor of medicine and urology at the David Geffen School of Medicine at UCLA and member of the UCLA Jonsson Comprehensive Cancer Center, in a press release."If the virus was the key and its receptor is the lock, then the virus inserts into the lock and can gain entry into the lung while the male hormones makes that lock more accessible to the virus. By suppressing the male hormones, it's kind of like putting a piece of masking tape over the lock so that the key won't fit in."

The medication will be used in COVID-positive men in hopes of reducing deaths and shortening hospital stays.

Read more about the trial.

Watch our latest HealthDay Now as we take a look at how living through the COVID-19 pandemic impacts children socially, mentally and emotionally.

One year in, this is their "new normal," but what does that mean for them? From social isolation to remote learning to a loss of structure and normalcy, we discuss how living during the pandemic has both short- and long-term effects on children.

Mabel Jong from our liveblog team speaks with:

  • Dr. Mark Reinecke, Department of Psychiatry & Behavioral Sciences, Northwestern University
  • Tracy Compton, a parent
  • Stephen Guerriero, a teacher
  • Jake Anderson, a student

Watch the in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

Watch our latest HD Live! as we take a look at the COVID-19 pandemic and the vaccination rollout and how they've impacted people of color.

Mabel Jong from our liveblog team speaks with:

  • Tasha Clark-Amar, CEO, East Baton Rouge Council on Aging
  • Jill Ramirez, Executive Director, Latino HealthCare Forum (Austin)
  • Vickie Mays, PhD, Professor, UCLA Fielding School of Public Health

Watch the in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

Watch our latest HD Live! as we take a look at the global COVID-19 vaccination rollout and how the United States rollout compares.

Mabel Jong from our liveblog team speaks with Dr. Ran Balicer of Clalit Health Services and Dr. Arnold Monto of University of Michigan School of Public Health.

Watch the in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

UPDATE 1/26/21: Since our HD Live! interview with CEO Andrei Doroshin, the Philadelphia Health Department has severed its ties with the organization. The nonprofit has changed its status to a for-profit entity.

Watch our latest HD Live! as we take a look at Philly Fighting Covid, a nonprofit organization run by graduate students from Drexel University that aims to help with mass COVID-19 vaccination in Philadelphia.

Mabel Jong from our liveblog team speaks with Andrei Doroshin, founder of Philly Fighting Covid.

Watch the in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

Latest